Dr. Andy Cho, M.D

NPI: 1063451367
Total Payments
$10,156
2024 Payments
$761.80
Companies
36
Transactions
168
Medicare Patients
6,659
Medicare Billing
$418,828

Payment Breakdown by Category

Other$6,415 (63.2%)
Food & Beverage$3,686 (36.3%)
Education$55.00 (0.5%)

Payments by Nature

Nature of Payment Amount Transactions Share
Current or prospective ownership or investment interest $6,415 2 63.2%
Food and Beverage $3,686 161 36.3%
Education $55.00 1 0.5%
Unspecified $0 4 0.0%

Payments by Type

General
$10,156
164 transactions
Ownership
$0
4 transactions

Top Paying Companies

Company Total Records Latest Year
Innovative Medical Technologies, LLC $6,415 6 $0 (2020)
NeoTract Inc. $600.34 7 $0 (2019)
Astellas Pharma US Inc $475.40 27 $0 (2023)
Sumitomo Pharma America, Inc. $309.01 16 $0 (2024)
Janssen Biotech, Inc. $241.82 19 $0 (2024)
PFIZER INC. $206.41 14 $0 (2024)
PROGENICS PHARMACEUTICALS, INC. $204.00 2 $0 (2024)
Amgen Inc. $188.33 11 $0 (2023)
Endo Pharmaceuticals Inc. $187.32 12 $0 (2024)
Olympus America Inc. $180.03 3 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $761.80 25 PROGENICS PHARMACEUTICALS, INC. ($185.22)
2023 $636.84 37 Sumitomo Pharma America, Inc. ($168.43)
2022 $504.11 23 Olympus America Inc. ($165.77)
2021 $320.45 20 Astellas Pharma US Inc ($129.94)
2020 $119.48 6 Astellas Pharma US Inc ($88.41)
2019 $546.10 22 NeoTract Inc. ($182.56)
2018 $491.52 22 NeoTract Inc. ($262.83)
2017 $6,776 13 Innovative Medical Technologies, LLC ($6,415)

All Payment Transactions

168 individual payment records from CMS Open Payments — Page 1 of 7

Date Company Product Nature Form Amount Type
12/17/2024 Sumitomo Pharma America, Inc. ORGOVYX (Drug) Food and Beverage In-kind items and services $21.83 General
Category: HORMONE THERAPY
12/11/2024 Merck Sharp & Dohme LLC KEYTRUDA (Biological) Food and Beverage In-kind items and services $16.04 General
Category: ONCOLOGY
12/04/2024 AstraZeneca Pharmaceuticals LP LYNPARZA (Drug) Food and Beverage In-kind items and services $17.63 General
Category: Oncology
12/03/2024 ABBVIE INC. BOTOX (Biological) Food and Beverage In-kind items and services $24.87 General
Category: BOTOX THERAPEUTIC
11/25/2024 Sumitomo Pharma America, Inc. GEMTESA (Drug) Food and Beverage In-kind items and services $26.19 General
Category: UROLOGY
10/17/2024 Boston Scientific Corporation LithoVue (Device) Food and Beverage In-kind items and services $33.91 General
Category: LithoVue_URO
10/16/2024 AstraZeneca Pharmaceuticals LP LYNPARZA (Drug) Food and Beverage In-kind items and services $18.13 General
Category: Oncology
10/09/2024 PFIZER INC. XTANDI (Drug), ORGOVYX, TALZENNA Food and Beverage In-kind items and services $23.81 General
Category: ONCOLOGY
09/10/2024 Sumitomo Pharma America, Inc. GEMTESA (Drug) Food and Beverage In-kind items and services $15.39 General
Category: UROLOGY
08/20/2024 PROGENICS PHARMACEUTICALS, INC. PYLARIFY (Drug) Food and Beverage In-kind items and services $185.22 General
Category: RADIOPHARMACEUTICAL
07/23/2024 Merck Sharp & Dohme LLC KEYTRUDA (Biological) Food and Beverage In-kind items and services $109.61 General
Category: ONCOLOGY
07/11/2024 UROGEN PHARMA, INC. JELMYTO (Drug) Food and Beverage In-kind items and services $17.27 General
Category: UROTHELIAL CANCER
07/03/2024 Sumitomo Pharma America, Inc. GEMTESA (Drug) Food and Beverage In-kind items and services $23.93 General
Category: UROLOGY
05/30/2024 AstraZeneca Pharmaceuticals LP LYNPARZA (Drug) Food and Beverage In-kind items and services $20.68 General
Category: Oncology
05/21/2024 Sumitomo Pharma America, Inc. GEMTESA (Drug) Food and Beverage In-kind items and services $11.84 General
Category: UROLOGY
05/16/2024 Sumitomo Pharma America, Inc. GEMTESA (Drug) Food and Beverage In-kind items and services $28.88 General
Category: UROLOGY
05/15/2024 Endo USA, Inc. XIAFLEX (Biological) Food and Beverage In-kind items and services $21.69 General
Category: UROLOGY
05/06/2024 Tolmar, Inc. JATENZO (Drug), ELIGARD Food and Beverage Cash or cash equivalent $14.44 General
Category: HORMONE REPLACEMENT
04/03/2024 Dendreon Pharmaceuticals LLC PROVENGE (Drug) Food and Beverage In-kind items and services $25.70 General
Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER
04/02/2024 Endo Pharmaceuticals Inc. AVEED (Biological), XIAFLEX Food and Beverage In-kind items and services $19.94 General
Category: UROLOGY
03/21/2024 UROGEN PHARMA, INC. JELMYTO (Drug) Food and Beverage In-kind items and services $16.18 General
Category: UROTHELIAL CANCER
03/05/2024 ACCORD HEALTHCARE, INC. CAMCEVI (Drug) Food and Beverage In-kind items and services $14.99 General
Category: Oncology
02/14/2024 Endo Pharmaceuticals Inc. AVEED (Biological), XIAFLEX Food and Beverage In-kind items and services $18.59 General
Category: UROLOGY
01/17/2024 Sumitomo Pharma America, Inc. ORGOVYX (Drug) Food and Beverage In-kind items and services $12.52 General
Category: HORMONE THERAPY
01/09/2024 Janssen Biotech, Inc. ERLEADA (Drug), AKEEGA Food and Beverage In-kind items and services $22.52 General
Category: Oncology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 27 1,611 4,604 $470,233 $109,951
2022 28 1,708 5,361 $483,539 $105,097
2021 31 1,764 4,916 $532,091 $117,105
2020 28 1,576 4,336 $446,042 $86,674
Total Patients
6,659
Total Services
19,217
Medicare Billing
$418,828
Procedure Codes
118

All Medicare Procedures & Services

118 procedure records from CMS Medicare Utilization — Page 1 of 5

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 376 437 $79,038 $23,954 30.3%
99426 Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month Office 2023 59 380 $68,988 $17,521 25.4%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 138 158 $44,301 $13,345 30.1%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 62 62 $25,644 $7,176 28.0%
52356 Crushing of stone of ureter with insertion of stent using an endoscope Facility 2023 18 18 $23,752 $5,591 23.5%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 47 49 $15,481 $4,912 31.7%
74178 Ct scan of abdomen and pelvis before and after contrast Office 2023 24 24 $26,385 $4,084 15.5%
52000 Diagnostic exam of bladder and urethra using an endoscope Office 2023 24 24 $12,925 $4,049 31.3%
99490 Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month Office 2023 11 81 $14,905 $3,748 25.1%
52000 Diagnostic exam of bladder and urethra using an endoscope Facility 2023 58 61 $24,414 $3,441 14.1%
52310 Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope Office 2023 14 14 $10,296 $3,161 30.7%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 39 39 $9,861 $2,470 25.1%
84153 Psa (prostate specific antigen) measurement, total Office 2023 114 128 $8,783 $2,291 26.1%
74176 Ct scan of abdomen and pelvis without contrast Office 2023 35 36 $19,799 $2,258 11.4%
99427 Principal care management services for a single high-risk disease, each additional 30 minutes of clinical staff time directed by health care professional, per calendar month Office 2023 30 52 $7,245 $1,863 25.7%
36415 Insertion of needle into vein for collection of blood sample Office 2023 170 210 $6,625 $1,764 26.6%
G0416 Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method Office 2023 13 13 $18,264 $1,753 9.6%
51798 Ultrasound measurement of bladder capacity after voiding Office 2023 146 187 $27,803 $1,254 4.5%
55700 Biopsy of prostate gland Facility 2023 13 13 $5,690 $1,161 20.4%
74018 X-ray of abdomen, 1 view Office 2023 48 62 $4,658 $1,037 22.3%
99231 Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes Facility 2023 21 22 $2,094 $843.92 40.3%
76770 Complete ultrasound scan behind abdominal cavity Office 2023 16 16 $4,071 $703.04 17.3%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2023 12 12 $1,956 $511.08 26.1%
74420 Imaging of urinary tract following injection of a contrast agent Facility 2023 15 18 $1,090 $337.32 30.9%
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml Office 2023 24 2,400 $4,800 $286.78 6.0%

About Dr. Andy Cho, M.D

Dr. Andy Cho, M.D is a Urology healthcare provider based in Gahanna, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1063451367.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Andy Cho, M.D has received a total of $10,156 in payments from pharmaceutical and medical device companies, with $761.80 received in 2024. These payments were reported across 168 transactions from 36 companies. The most common payment nature is "Current or prospective ownership or investment interest" ($6,415).

As a Medicare-enrolled provider, Cho has provided services to 6,659 Medicare beneficiaries, totaling 19,217 services with total Medicare billing of $418,828. Data is available for 4 years (2020–2023), covering 118 distinct procedure/service records.

Practice Information

  • Specialty Urology
  • Location Gahanna, OH
  • Active Since 06/05/2006
  • Last Updated 02/13/2020
  • Taxonomy Code 208800000X
  • Entity Type Individual
  • NPI Number 1063451367

Products in Payments

  • UroLift (Device) $445.39
  • GEMTESA (Drug) $274.66
  • XTANDI (Drug) $239.52
  • PYLARIFY (Drug) $204.00
  • MYRBETRIQ (Drug) $186.35
  • iTIND System (Device) $180.03
  • Erleada (Drug) $179.28
  • Urolift - UL400 (Device) $154.95
  • KEYTRUDA (Biological) $144.37
  • XIAFLEX (Biological) $122.64
  • JELMYTO (Drug) $119.87
  • REZUM (Device) $119.32
  • Prolia (Biological) $113.14
  • Myrbetriq (Drug) $104.17
  • AVEED (Biological) $86.37
  • Xtandi (Drug) $84.48
  • PROVENGE (Drug) $79.67
  • XGEVA (Biological) $75.19
  • Rezum (Device) $67.83
  • ORGOVYX (Drug) $61.61

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Urology Doctors in Gahanna